Navigation Links
Studies Presented at Neurology Conference Highlight Early Efficacy,,Long-Term Tolerability, and High Patient Satisfaction with,Betaseron

BOSTON, May 03, 2007 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals announced today the results of three clinical studies with Betaseron(R) (interferon beta-1b), presented this week at the American Academy of Neurology's (AAN) 59th Annual Meeting, demonstrating early efficacy, long-term tolerability, and high patient satisfaction with treatment in patients with relapsing forms of multiple sclerosis (MS).

"Collectively, these studies highlight the important clinical benefits and long-term safety and tolerability of Betaseron treatment," said Ludger Heeck, Ph.D., Vice President and General Manager, Specialized Therapeutics, Bayer HealthCare Pharmaceuticals. "Betaseron is the first immunomodulatory MS treatment shown to significantly delay disability and disease progression in patients with the first event suggestive of MS. In addition, key attributes, such as a high level of patient satisfaction and tolerability of the medication, may help improve a person's adherence to treatment and consequently, the effectiveness of the treatment."

In the first study, known as BENEFIT(1) (BEtaseron in Newly Emerging multiple sclerosis For Initial Treatment), immediate initiation of Betaseron(R) treatment in patients after a first event suggestive of MS significantly reduced the risk of disability as measured by the Expanded Disability Status Scale (EDSS) by 40 percent(2). The results of the prospectively designed and blinded study were measured over three years and compared early treatment to delayed treatment, defined as receiving treatment after the second clinical event or after two years.

The second study - known as the Betaseron 16-Year Long-Term Follow-up (16- Year LTF) Study(3)- found long-term(4) use of Betaseron to be safe and tolerable. The 16-Year LTF Study followed patients with the relapsing form of MS who had already participated in the pivotal Betaseron trial, the results of which led to t
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
2. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
3. Studies of Drug Resistance May Lead to Individual Therapy for Rare Cancers
4. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
5. Insmed Inc. Welcomes Studies Linking IGFBP-3 to Prevention of Blindness in Premature Infants
6. Resveratrol Studies Suggest Broad Implications for SIRT1 Activation in Neurodegenerative Diseases of Aging Such as Alzheimers Disease
7. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
8. Phosphagenics Announces Positive Proof of Concept Results from Studies Utilizing Companys Dermal Drug Delivery Technology
9. New Data from Multiple Studies Show Galvus Delivers Consistent and Robust Blood Sugar Control in Patients with Type 2 Diabetes
10. Eurands Zentase Effective in Treating Exocrine Pancreatic Insufficiency, Studies Show
11. Three Studies Suggest Abbotts Humira (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis
Post Your Comments:
(Date:7/2/2015)... BGI a annoncé aujourd,hui que son ... situé à Hong Kong ... Pathologists  (Collège des pathologistes américains, ou CAP). Les ... constituent le premier laboratoire clinique de ... du CAP en Chine, car il satisfait les ...
(Date:7/2/2015)... FORT LAUDERDALE, Fla. , July 2, 2015 ... & Co., is pleased to announce that its ... Inc. ("Insight Beverages") to Kerry Group plc (ISE: ... focused on taste and nutrition systems, as well ... food, beverage and pharmaceutical markets. Farlie Turner served ...
(Date:7/2/2015)... 26, 2015 Research and Markets( ... D Market by Analog, Application, End-User & by Region - ... offering. This market is projected to reach about ... in different applications and rising opportunities in countries such as ... Italy , and Brazil ...
Breaking Medicine Technology:BGI obtient la certification du Collège des pathologistes américains (CAP) 2Farlie Turner's Consumer Group Completes Sale of Insight Beverages to Kerry 2Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 2Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 3
(Date:7/3/2015)... ... July 03, 2015 , ... ... healthcare providers, has been retained to lead a national chief nursing officer ... top-ranked executive search firms in the healthcare industry, B. E. Smith has recently ...
(Date:7/3/2015)... ... 2015 , ... First Choice Emergency Room , the largest network of ... the new Medical Director of its Frisco facility. , “We are pleased to announce ... Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , ...
(Date:7/2/2015)... ... July 02, 2015 , ... sweetFrog Enterprises, LLC. is pleased to ... the first sweetFrog store located in Mississippi. The premium frozen yogurt chain was listed ... The store, located at 104 Railroad Avenue, New Albany, MS 38652, will have a ...
(Date:7/2/2015)... ... July 02, 2015 , ... When Walker ... at the University of Minnesota, they knew it would save the university energy ... an award-winning choice: the total energy savings after installation was an impressive 89 ...
(Date:7/2/2015)... ... July 02, 2015 , ... As Americans celebrate the Fourth of July ... cancer is on the rise. July is UV Safety Month, and physicians at American ... importance of getting skin checks. Experts say most skin cancers can be found early ...
Breaking Medicine News(10 mins):Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 3Health News:sweetfrog Opens First Location in Mississippi 2Health News:Kenall’s TekDek™ Helps University Achieve Award-Winning Energy Savings in Parking Structure Lighting Retrofit 2Health News:Local Physicians Warn of Holiday Health Hazards 2Health News:Local Physicians Warn of Holiday Health Hazards 3Health News:Local Physicians Warn of Holiday Health Hazards 4
... WINSTON-SALEM, N.C. Sept. 16, 2011 A study ... colleagues suggests that a high intake of calcium causes ... absorbers of the mineral. "High dietary intake of ... the explanation for this observation has been elusive," said ...
... THURSDAY, Sept. 15 (HealthDay News) -- The rate of new lung ... as it has for men in for years, a new U.S. ... 2.2 percent per year on average for women between 2006 and ... 2006, according to the U.S. Centers for Disease Control and Prevention. ...
... speaking on Capitol Hill today demonstrated that the Great ... older workers, although programs such as the federal Senior ... some valuable benefits to this disadvantaged demographic group. ... of National Employ Older Workers Week was titled, ...
... of young children admitted to hospitals or seen in ... dose of medication has risen dramatically in recent years, ... study. The rise in exposure to ... for Disease Control and Prevention has established the PROTECT ...
... Alzheimer,s diagnosis presents new challenges to the public, physicians and ... you want to know? How should doctors tell you your ... diagnosed Americans still in the workplace? Despite the ... effective interventions have been identified to stop the progression of ...
... , THURSDAY, Sept. 15 (HealthDay News) -- Men and women ... their eyelids appear to face a higher risk of heart ... new Danish research suggests. The link between the skin ... rather than a clear case of "cause and effect." ...
Cached Medicine News:Health News:Genetics may explain why calcium increases risk for prostate cancer 2Health News:Lung Cancer Rates Begin to Decline for U.S. Women 2Health News:Congressional briefing sheds light on poor seniors' employment struggles 2Health News:Congressional briefing sheds light on poor seniors' employment struggles 3Health News:Number of children poisoned by medication rising dramatically, study says 2Health News:Safeguards needed to prevent discrimination of early Alzheimer's patients in the workplace 2Health News:Cholesterol Deposits Around Eyes Linked to Heart Risk 2
... Complete procedure information to facilitate diagnostic ... monitor is a sterile, disposable device used ... nucleus during discography procedures. The device will ... display it in a digital format. The ...
Smith & Nephew's CDS System is developed exclusively for discography., Developed exclusively for discography, it is the first system designed to measure true disc pressure and record real-time proce...
The ACCU-DISC™ pressure monitoring system offers the advantage of accurate delivery of fluids to the body with the ability to monitor the pressure of those fluids in discography interpretation....
The °CureWrap is one-piece garment offers maximum available surface coverage, while avoiding the sterilized fields of operation....
Medicine Products: